Transcription of the c-fos proto-oncogene is rapidly induced by serum growth factors. A short c-fos DNA element, the serum response element (SRE), is required for this response to serum. However, serum activates a series of distinct intracellular signaling pathways, and it is not known to which of these pathways the SRE responds. To address this question, mutations have been introduced into the SRE of an otherwise intact c-fos promoter/enhancer. These mutations strongly reduce the binding of a nuclear factor to this site. Plasmids carrying either a wild-type or mutant c-fos SRE were transfected into fibroblasts and tested for their response to whole serum, purified recombinant c-sis protein, the protein kinase C activator phorbol myristate acetate, and activators of the cyclic AMP (cAMP) second messenger system. Assays were carried out under normal conditions and after chronic phorbol ester-treatment to deplete phorbol ester activatable protein kinase C activity from transfected cells. The results show that the SRE is necessary and sufficient for response to both protein kinase C--dependent and-independent intracellular signaling pathways but not for response to the cAMP pathway.
20-bp region of hyphenated dyad symmetry located 300 bp upstream of the c-fos cap site is both necessary and sufficient for the response of c-fos to whole serum in fibroblasts (Treisman 1985 (Treisman , 1986 Gilman et al. 1986; Greenberg et al. 1987) . Deletion of the SRE abolishes induction by serum, whereas an oligonucleotide carrying a single copy of the sequence is sufficient to restore serum responsiveness to a deleted c-fos promoter. This sequence is a binding site for a protein factor found in nuclear extracts of a variety of cell types (Gilman et al. 1986; Prywes and Roeder 1986; Treisman 1986; Greenberg et al. 1987) . Mutations in the SRE that affect the binding of this protein also affect the biological activity of the element (Greenberg et al. 1987; Treisman 1987) . HeLa cell proteins that bind to the SRE have recently been purified Schroter et al. 1987; Treisman 1987) . Such proteins are potentially recipients of incoming signals that activate c-fos transcription.
Although the SRE is critical for the response of the c-fos gene to serum, it is not yet clear to which intracellular signals it responds. Serum is a complex mixture of growth factors and hormones, each of which may activate multiple second messengers. To determine which intracellular signaling pathways use the SRE and which use other sequence elements in the c-fos gene, point mutations have been introduced into the SRE and the resulting mutants have been tested for response to a set of purified growth factors and intracellular second messengers. The results suggest that in fibroblasts, at least three distinguishable intracellular signaling pathways reach the c-fos gene. Two pathways act through the SRE, whereas a third is completely independent of this element.
Results

Point mutations in the SRE abolish factor binding in vitro
The strategy used to evaluate the role of the SRE in the response of the c-fos gene to various stimuli was to inactivate the element in an otherwise intact mouse c-fos promoter-enhancer region and to test the resulting mutant for response to appropriate stimuli in mouse fibroblasts. Previous studies have identified critical nucleotides in the SRE required for binding of a nuclear protein that is presumed to mediate its activity (Gilman et al. 1986; Treisman 1986 ). These contact residues are two pairs of adjacent guanosines that are situated symmetrically within the SRE. Using site-directed mutagenesis, all four guanosines were mutated to cytosines (pml2 mutations; Fig. 1A ), preserving the dyad symmetry of the element. Wild-type and mutant c-fos sequences from -3 5 6 to + 109 were fused to the bacterial gene encoding chloramphenicol acetyltransferase (CAT). By using fusion genes, transcripts of the transfected gene could be distinguished easily from transcripts of the endogenous mouse c-fos gene in the transfected cultures.
The mutant SRE was first tested for its ability to bind the nuclear SRE-binding factor present in WEHI 231 cells (Gilman et al. 1986) . Figure 2 shows a mobilityshift assay performed with a labeled c-fos DNA fragment (-356 to -274) carrying a wild-type SRE. Lane 2 shows the specific complex formed on this fragment in WEHI 231 nuclear extracts. When increasing amounts of an unlabeled purified c-fos restriction fragment (-356 to + 109} also carrying a wild-type SRE were added to the binding reaction, binding to the wild-type probe was reduced as factor was diverted to the unlabeled competitor fragment (lanes 3-6). When a similar competitor fragment carrying the pml2 mutations in the SRE was added to the reaction, binding to the probe was unaffected at up to 100-fold molar excess of competitor (lanes 7-10). Thus, the pml2 mutant SRE binds this protein in vitro with at least two orders of magnitude lower affinity than does the wild-type site.
Effect of SRE point mutations on c-fos induction in vivo
c-los-CAT fusion genes carrying either a wild-type or a pml2 mutant SRE were tested for their response to several types of stimuli. Plasmids carrying the fusion genes were transfected into BALB/c 3T3 cells, together with a plasmid carrying the human ~-globin gene; the latter plasmid served as an internal control for transfection elficiency. After transfection, the cells were incubated in medium containing 0.5% calf serum for approximately 48 hr and then fed with either serum-flee medium (NA in Figs. 3-6} or serum-free medium containing the following additions: 10% calf serum (CS); 40 ng/ml recombinant c-sis protein (SIS), a purified polypeptide growth factor that acts indistinguishably from authentic platelet-derived growth factor (PDGF); 50 ng/ml phorbol myristate acetate (PMA), an activator of protein kinase C (pkC); 0.5 mM isobutylmethylxanthine (IBMX), a phosphodiesterase inhibitor, and 10 ~ZM forskolin, an activator of adenylate cyclase (IF). After an additional 45-rain incubation, the cells were harvested, and total cytoplasmic RNA was prepared.
RNA was assayed by RNase protection using probes specific for c-fos and ~-globin transcripts. The c-fos probe hybridizes to transcripts of the transfected c-fos- This signal provides a control for the efficacy of induction for each dish of cells. The smallest fragment (95 nucleotides, marked a) derives from correctly initiated transcripts of the cotransfected a-globin gene. This signal provides a measure of the transfection efficiency for each dish. Because all dishes transfected with the same plasmids received aliquots of a single large transfection precipitate, transfection efficiencies were generally equivalent within that set of dishes, allowing direct transcripts; (a) fragments protected by transcripts of the aglobin control plasmid. Note that the relative intensities of the a-globin bands show that the dishes that received -356 pml2 DNA were transfected with lower efficiency than the dishes that received the wild-type plasmid. This difference in transfection efficiency accounts for much of the absolute difference in signal intensity for the transfected genes.
cells were induced normally, showing that the reduction in response of the transfected genes was due to the introduced mutations, not to the absence of an inducing signal. The residual response of the pml2 mutant to c-sis is reproducibly seen, although the magnitude is highly variable. That the pml2 mutations do affect c-sis response may be seen by comparing the c-sis signal to that obtained with IBMX and forskolin. Induction by c-sis is stronger than IBMX and forskolin, with the wildtype gene, whereas induction by c-sis is weaker with the mutant. This experiment, together with the binding assays shown in Figure 2 , confirms that an intact protein-binding site is required for the serum response (Greenberg et al. 1987; Treisman 1987 ). Furthermore, it shows that the SRE is also required for c-fos induction by PMA, presumably through activation of pkC and for full response to c-sis protein. Third, this experiment suggests that c-fos induction via the cAMP second messenger system does not require an intact SRE and that sequences sufficient for this response lie elsewhere in the gene. The previous experiment showed that c-fos activation by serum, c-sis, and PMA requires the SRE. PMA is thought to act largely through activation of pkC, but serum growth factors act through other pathways besides pkC. To determine whether the SRE was required for response to pkC-independent signals, transfected c-fos genes were induced in cells depleted of pkC activity. Cultures of cells were transfected with either the wild-type or the pml2 c-fos-CAT fusion genes. Immediately following transfection, cells were treated for 48 hr with medium containing 0.5% calf serum and 100 ng/ml phorbol dibutyrate (PDBu). Control cultures received the solvent dimethylsulfoxide (DMSO). Chronic treatment with active phorbol esters results in downregulation of pkC and the disappearance of assayable pkC activity in extracts of the treated cells (Collins and Rozengurt 1984; Rodriguez-Pena and Rozengurt 1984) . Therefore, this protocol establishes a temporary state in which cells are deficient in phorbol ester-activatable pkC, and any residual growth factor-induced response is presumably due to signaling pathways independent of such enzymes. Although endogenous c-fos expression in control cultures was induced by all stimuli (Fig. 4 , left panell, the PDBu-treated cultures were refractory to induction by PMA (Fig. 4 , middle and right panels), suggesting that these cells lacked PMA-activatable pkC. Induction by serum and c-sis was partially reduced, suggesting a partial reliance on pkC. Induction by IBMX and forskolin was largely unaffected, suggesting that this pathway is pkC independent. Under these conditions, the transfected wild-type fusion gene still responded to serum and c-sis (middle panel), though not as strongly as in the control cells. Therefore, this gene must carry sequences sufficient for response to pkC-independent signals. Mutations in the SRE abolished response to serum and c-sis in the pkC-deficient cells (Fig. 4, right  panel) . Induction by IBMX and forskolin was again unaffected by the SRE mutations. Thus, this experiment establishes that in addition to the pkC pathway, the SRE is required for response to one or more pkC-independent pathways triggered by serum and c-sis.
An SRE oligonucleotide confers responsiveness to both pk C-depen den t an d -in depen den t sign aling pa th ways
Short oligonucleotides carrying the SRE restore serum inducibility to deleted c-fos and heterologous promoters (Treisman 1986 (Treisman , 1987 Greenberg et al. 1987; Mohun et al. 1987) . To determine whether the SRE alone is sufficient for response to different signaling pathways, synthetic oligonucleotides encoding 22 bp of wild-type SRE sequence or the corresponding sequence carrying the pml2 mutations (see Fig. 1A ) were inserted just upstream of a deleted c-fos-CAT fusion gene. The deleted gene carries c-fos sequences through -151 and includes several basal promoter elements (Gilman et al. 1986 ). Figure 5 shows that the parental -151 construct responds weakly, if at all, to serum, c-sis, and PMA, although it does respond to IBMX and forskolin (left panel). Insertion of a single copy of the wild-type SRE oligonucleotide immediately upstream restores response The same constructs carrying the wild-type and pm 12 SRE oligonucleotides were transfected into cells, and the cells were treated for 48 hr with PDBu, as described previously. Figure 6 shows that genes carrying a mutant SRE oligonucleotide responded only to IBMX and forskolin (left panel). Genes with a wild-type oligonucleotide were also induced by serum and c-sis (right panel).
Thus, the SRE is also sufficient for response to growth factor-activated pkC-independent pathways operating in these cells. Therefore, the SRE is necessary and sufficient for the response of c-fos to at least two distinct intracellular signaling pathways, one dependent on pkC, and one or more pkC-independent pathways. The SRE does not appear to play a direct role in the response to cyclic nucleotide-mediated signals.
D i s c u s s i o n
The c-los proto-oncogene is a highly inducible gene that is sensitively coupled to external signals. Transcription of c-fos is activated in response to signals that are diverse in both their chemical structures and biological activities. Previous work has shown that a single sequence element, the SRE, is essential for the response of c-los to whole serum (Treisman 1985 (Treisman , 1986 Gilman et al. 1986; Greenberg et al. 1987) . But serum is a complex mixture of biologically active agents, with cooperating and antagonistic activities on cells. Furthermore, constituents of serum activate several distinct intracellular signaling pathways. The goal of the studies described here was to determine which of these pathways act on the c-fos gene through the SRE and which require other sequences. Fresh serum and several purified growth factors stimulate inositol phospholipid turnover in sensitive cells (for review, see Michell and Putney 1987) . One product of this reaction is diacylglycerol, which activates a family of closely related protein kinases known as pkC (Nishizuka 1986 ). This intracellular signaling pathway appears to communicate with the c-fos gene primarily through 
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These data also show that serum and c-sis transmit signals to the c-fos gene that are independent of phorbol ester-activatable pkC, as shown previously by others (Stumpo and Blackshear 1986; Blackshear et al. 1987; Bravo et al. 1987) and show further that these signals act through the SRE. The nature of these signals is unclear. pkC is now known to comprise a large family of enzymes, some of which may not be depleted by phorbol ester treatment Knopf et al. 1986; Makowske et al. 1986; Ono et al. 1986; Parker et al. 1986; Housey et al. 1987) . Therefore, involvement of some form of pkC in c-fos induction after chronic phorbol ester treatment cannot be ruled out formally. Another candidate signal that could operate under these conditions is the increase in cytoplasmic calcium levels that is also a consequence of inositol phospholipid turnover. Indeed, in many cell types, agents that act to increase intracellular calcium levels induce c-fos expression efficiently (Bravo et al. 1985 (Bravo et al. , 1987 Milbrandt 1986; Moore et al. 1986; Morgan and Curran 1986) . However, in the cells used here, calcium ionophores fail to induce c-los expression significantly (data not shown), an observation also reported for another clone of BALB/c 3T3 cells (Ran et al. 1986 ). Therefore, the identity of the growth factor-induced signaling pathways that act on c-fos under these conditions is not known.
Another intracellular signal that induces c-fos expression in some cells is accumulation of intracellular cAMP. Agents that increase intracellular cAMP are reported to induce transient c-fos expression in the PC-12 pheochromocytoma cell line (Greenberg et al. 1985; Kruijer et al. 1985) but not in two fibroblast lines (Ran et al. 1986; Bravo et al. 1987) . In macrophages, cAMP induces c-fos but with markedly different kinetics (Bravo et al. 1987 ). In the fibroblast line used in the present experiments, induction by cAMP is rapid and transient, although relatively weak and with slightly slower kinetics than induction by serum (L.A. Berkowitz and M.Z. Gilman, unpubl.) . It has not yet been directly shown that treatment of these cells with IBMX and forskolin significantly augments cellular cAMP levels. However, this pathway has sequence requirements distinct from the other two pathways examined. It is independent of the SRE and requires, at least in part, c-fos sequences between -151 and +109. It has been noted that the c-fos gene contains sequences located at -290 and -65 with similarity to cAMP regulatory elements in other genes (Comb et al. 1986; Montminy et al. 1986 ). The c-fos gene also contains several matches to the consensus binding site for transcription factor AP-2 Mitchell et al. 1987) , and polymerized binding sites for this factor are cAMP responsive in vivo . A reproducible observation in these experiments was the slight induction of the pml2 mutants with c-sis (see Figs. 3 and 4) . The variable nature of the residual induction obtained with the mutant suggests that this construct may be responding to a signaling pathway that is variably active in these cells, depending on the precise growth conditions (Ran et al. 1986; Rollins et al. 1987) . This observation raises the possibility that other sequences in the c-fos gene are capable of specifically responding to c-sis or PDGF. One candidate is a sequence 25 bp upstream of the SRE that binds a cellular factor specifically induced by conditioned medium from v-sistransformed cells (Hayes et al. 1987 ). However, induction by c-sis in both the presence and absence of pkC is strongly affected by SRE mutations (Figs. 3 and 4) , suggesting a major role for the SRE, and induction by c-sis also occurs in the absence of this upstream sequence (Figs. 5 and 6). A second possible explanation for induction of the pm12 mutant by c-sis is that this induction is due to effects on intracellular cAMP concentrations elicited by PDGF (Rozengurt et al. 1983) . Arguing against this model is the observation that c-fos constructs containing sequences through -151 and lacking an SRE fail to respond to c-sis, although they do respond to IBMX and forskolin (Figs. 5 and 6). Additional mutagenesis studies will be necessary to distinguish between these alternatives. How are the distinct signals that act through the SRE coupled to c-fos transcription? One possibility is that these pathways converge, each acting through the same SRE-binding protein. An alternate possibility is that each pathway communicates with a unique or dedicated SRE-binding protein.
Only one SRE-binding activity is detected in nuclear extracts using the mobility-shift assay, but the presence of this activity in extracts does not correlate perfectly with the transcriptional activity of the c-fos gene. For example, the activity is present in many extracts of cells not transcribing c-fos (Gilman et al. 1986; Prywes and Roeder 1986; Treisman 1986; Fisch et al. 1987; Greenberg et al. 1987; Stumpo et al. 1988) . It is reported absent in cells in which c-fos transcription has been induced with PMA or calcium ionophore (Prywes and Roeder 1986) . Nevertheless, the results presented here suggest that cellular proteins with the binding specificity of this nuclear factor are indeed re-quired for response to PMA and to pkC-independent signals. Therefore, if these pathways all act through this single factor, its activity does not appear to be strictly regulated through control of its DNA-binding activity, in contrast to factors that bind to other PMA-inducible elements (Sen and Baltimore 1986; Angel et al. 1987; Franza et al. 1987; Dinter et al. 1987; Nabel and Baltimore 1987; Wu et al. 1988) . Alternatively, there may be additional SRE-binding proteins not detected by the mobility-shift assay. With the recent purification of HeLa cell proteins that bind to the SRE Schroter et al. 1987; Treisman 1987 ) direct data bearing on the roles cellular proteins play in c-los induction may soon be available.
Materials and methods
Materials
PMA, PDBu, forskolin, and IBMX were obtained from Sigma. PMA stocks were made up at 100 ~zg/ml (162 ~M) in DMSO. Forskolin stocks were 10 mM in ethanol. IBMX stocks were 0.5 M in DMSO. Final concentrations of DMSO and ethanol applied to cells were no more than 0.1% (vol/vol). At these concentrations, the solvents had no effect on c-fos expression, c-sis protein, B-chain homodimers of PDGF, was purchased from Amgen Biologicals.
Plasmids and mutagenesis
Most of the mouse c-fos-CAT fusion plasmids used in these studies were described previously (Gilman et al. 1986 ). For mu-
tagenesis, a HindIII-EcoRI fragment from the &-356 c-fos-CAT
fusion was transferred to M13 mpl 1. Mutagenesis was carried out with the two-primer method described by Zoller and Smith (1984) and was done in two steps. In the first step, the 3' pair of G-C base pairs was mutagenized using the oligonucleotide 5'-CGCAGATGTGGTAATATGGACATCCTG-3'. The resulting mutant was mutagenized further using the oligonucleotide 5'-TAATATCCACATCCTGTGTAAAGGAGG-3'. Mutant phage were identified by plaque hybridization using the mutagenic oligonucleotides, plaque purified, and sequenced. Mutant c-los-CAT fragments were recloned into plasmid vectors. SRE oligonucleotides (5'-GTCGGATGTCCATATTAGGA-CATCT-3' and 5'-GACAGATGTCCTAATATGGACATCC-3' for wild-type; 5'-GTCGGATGTGGATATTACCACATCT-3' and 5'-GACAGATCTGGTAATATCCACATCC-3' for prnl2) were phosphorylated, annealed, ligated briefly, and treated with the Klenow fragment of DNA polymerase to blunt overhanging ends. These mixtures of tandemty repeated oligonucleotides were cloned into the HincII site of pUCII9 and screened by DNA sequence analysis. Restriction fragments carrying the cloned oligonucleotides were recovered as HindIII-SalI fragments and inserted between the HindlII and SalI sites immediately upstream of the c-los promoter sequences in c-fos-CAT A-151 (Gilman et al. 1986 ).
All plasmid constructions were verified by DNA sequence analysis. Plasmids for transfections were purified twice in CsC1/EtBr gradients. DNA concentrations were determined by UV absorbance and confirmed by agarose gel electrophoresis.
Mobility-shift assay
The assay procedures, extracts, and probes were described in detail in Gilman et al. (1986) . Competitor fragments were prepared by digestion of the A-356wt and A-356pm12 plasmids with HindIII and BamHI, and purification by polyacrylamide gel electrophoresis of the 484-bp fragment carrying c-fos sequences -356 to + 109. The concentrations of the purified fragments were estimated by comparison to standards on polyacrylamide gels.
Transfections
BALB/c 3T3 cells were carried in Dulbecco's modified essential medium (DMEM) containing 10% calf serum and antibiotics. Cells were split 1 : 6 to 1 : 12 for 12-24 hr prior to transfection, so that cultures were approximately 20-30% confluent at transfection. Cells were fed with 9 ml warm fresh medium 1 hr before transfection. Cells were transfected using a calcium phosphate coprecipitation procedure, c-fos-CAT DNA (52 ~g) and ~rSVHPe~2 (Treisman et al. 1983 ) DNA (10.4 ~g) were diluted to 2.6 ml of 10 mM Tris (pH 7.5), 1 mM EDTA, and 250 mN CaCIz. This solution was added with gentle vortexing to 2.6 ml of 50 mM HEPES (pH 7.12), 280 mN NaC1, and 1.5 mlvi Na2HPO 4. The precipitate was allowed to stand for 2 min and then distributed in 1-ml aliquots onto five dishes. Each plate of cells received 10 txg of c-los-CAT DNA and 2 ~zg of the internal control plasmid -rrSVHPa2. All plates receiving the same constructions received aliquots of the same large precipitate, minimizing plate-to-plate variability among these dishes. Cells were incubated in the precipitates for 16-18 hr at 37~ The monolayers were washed three times with warm phosphate-buffered saline (PBS) and refed with 10 ml of DMEM containing 0.5% calf serum. Incubation continued for 48 hr at 37~ The medium was removed, the cells were washed once with warm PBS, and inducers were added in 3-ml serum-free DMEM. The control cells were handled identically and incubated in 3-ml serum-free DMEM alone. After 45 min at 37~ the medium was removed, and cells were placed on ice and flooded with ice-cold PBS. The monolayers were washed a total of three times with ice-cold PBS prior to RNA extraction. pkC down-regulation experiments were carried out identically, except that after transfection, cells received DMEM containing 0.5% calf serum and 100 ng/ml PDBu. Control cultures received the same medium with an equal amount of DMSO (0.1%1.
RNA analysis
Total cytoplasmic RNA was prepared essentially as described previously (Gilman et al. 1988 ) with two modifications. The cytoplasmic extract was treated with 125 izg/ml proteinase K for 15 min at 37~ prior to organic extraction. Second, the precipitated cytoplasmic RNA was treated with DNase I as follows. The RNA pellets were redissolved in 50 ixl RNase-free TE buffer. Following the addition of 50 Ixl of a solution containing 10 mM Tris [pH 8), 1 mM EDTA, 20 mM MgC12, 2 mM dithiothreitol, 500 U/ml RNasin (Promega), and 200 U/ml RNase-free DNase I (Worthington DPRF), the RNA was incubated for 15 min at 37~ DNase digestion was stopped by the addition of 25 p.l of a solution containing 50 nan EDTA, 1% (wt/vol) SDS, and 1.5 M sodium acetate. RNA was finally recovered by extraction with phenol/chloroform/isoamyl alcohol (25 : 24 : 1) and chloroform/isoamyl alcohol I24 : 1), followed by ethanol precipitation.
RNase protection assays were carried out as outlined in Melton et al. (1984) , with a number of modifications. Probes were prepared with either SP6 or T3 RNA polymerases using 100 btCi e~-[azP]CTP and were gel purified before use. Hybridizations contained 10 ~g total cytoplasmic RNA, 500,000 dpm c-fos probe, and 200,000 dpm of e~-globin probe in a total volume of 30 ~xl. Hybridization mixtures were incubated for 5 min at 85~ and then overnight (8-16 hr) at 45~ RNase digestions were carried out for 60 min at room temperature and contained only RNase T1 (2 ~g/ml). Electrophoresis was on 8% (wt/vol) polyacrylamide, 50% (wt/vol) urea sequencing gels.
The c-los probe was prepared from a plasmid carrying c-fos sequences from -56 to + 109 [nucleotides 79-243 in Van Beveren et al. (1983) ]. The plasmid was prepared by inserting a HindIII-BamHI fragment from c-fos-CAT fusion plasmid A-56 (Gilman et al. 1986 ) into HindIII-BamHI-digested pSP65. Plasmid DNA was linearized with HindIII and transcribed with SP6 RNA polymerase {New England Biolabs) to yield a 225-nucleotide probe containing c-los sequences found in transcripts of both the endogenous c-fos gene and the transfected genes and flanking linker sequences present only in the transfected gene transcripts (see Fig. 1B ). The c~-globin probe was prepared from a plasmid consisting of a 110 bp BssHII fragment of the human ~-globin gene (-15 to +95) cloned into the HindIII site of pBSM13 + (Stratagene). The probe was prepared by transcription of XbaI-digested template with T3 RNA polymerase (Stratagene).
In the figures, the major protected bands correspond to RNase T1 cleavage of the probes at the guanosine residues nearest the hybrid boundaries. Therefore, they do not indicate the precise 5'-end of the transcripts. Weak bands running above the major cleavage products represent incomplete RNase T1 digestion products that are cleaved at the next guanosine residue either upstream or downstream of the hybrid.
